Sharp Therapeutics Corp., a preclinical-stage drug discovery company, developes therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies, enables discovery of compounds that correct the mutational defect; AlloChem, a compound library, binds proteins allosterically, thus stabilizing and activating them; And Mine, a proprietary IP-protected analytics platform, captures all data for all AlloChem compounds in all CoreX assays. Sharp Therapeutics Corp. is headquartered in Pittsburgh, Pennsylvania.

Sector

Industry

CEO

Sneddon, Scott

Employees

Website

www.sharptx.com

IPO Date

Headquarters

2403 Sidney Street, Suite 264, Pittsburgh, Pennsylvania, 15203, United States

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Sharp Therapeutics SHRX

Sharp Therapeutics Earnings Call Summary

Sharp Therapeutics Earnings

Transcripts

Events

About Sharp Therapeutics Corp.

Sharp Therapeutics
SHRX